Zogenix Inc

-0.11 (-0.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.05B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$11.74 Million
Adjusted EPS-$1.02
See more estimates
10-Day MA$19.27
50-Day MA$20.62
200-Day MA$21.66
See more pivots

Zogenix, Inc. Stock, NASDAQ:ZGNX

5959 Horton Street, 5th floor, Emeryville, California 94608
United States of America
Phone: +1.858.259.1165
Number of Employees: 141


Zogenix, Inc. is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.